Clinical Trial Update: Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells

View source ↗

Summary

This completed clinical trial investigates how microRNAs and antigen-presenting cells regulate immune responses in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Multiple Sclerosis | Status: COMPLETED